Better Buy: Celldex Therapeutics, Inc. vs. Juno Therapeutics
Celldex Therapeutics (NASDAQ: CLDX) and Juno Therapeutics (NASDAQ: JUNO) are both once-promising clinical-stage biotechs that have fallen on extremely hard times of late. Over the past two and half years, for example, these former stars have each lost a staggering amount of their value:
Source: Fool.com
Celldex Therapeutics Stock
€35.60
-11.280%
We see a rather positive sentiment for Celldex Therapeutics with 18 Buy predictions and 1 Sell predictions.
With a target price of 62 € there is a hugely positive potential of 74.16% for Celldex Therapeutics compared to the current price of 35.6 €.
